BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31909866)

  • 1. Cost-analysis of persistent hyperkalaemia in non-dialysis chronic kidney disease patients under nephrology care in Italy.
    Provenzano M; De Francesco M; Iannazzo S; Garofalo C; Andreucci M; Genualdo R; Borrelli S; Minutolo R; Conte G; De Nicola L
    Int J Clin Pract; 2020 May; 74(5):e13475. PubMed ID: 31909866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease.
    Evans M; Palaka E; Furuland H; Bennett H; Linde C; Qin L; McEwan P; Bakhai A
    BMC Nephrol; 2019 Jan; 20(1):31. PubMed ID: 30704421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receipt of Nephrology Care and Clinical Outcomes Among Veterans With Advanced CKD.
    Fung E; Chang TI; Chertow GM; Thomas IC; Asch SM; Kurella Tamura M
    Am J Kidney Dis; 2017 Nov; 70(5):705-714. PubMed ID: 28811048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of hyperkalemia with clinical outcomes in advanced chronic kidney disease.
    Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
    Nefrologia (Engl Ed); 2019; 39(5):513-522. PubMed ID: 31027897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare costs of the progression of chronic kidney disease and different dialysis techniques estimated through administrative database analysis.
    Roggeri A; Roggeri DP; Zocchetti C; Bersani M; Conte F; ;
    J Nephrol; 2017 Apr; 30(2):263-269. PubMed ID: 27165160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hyperkalemia in patients with kidney disease: a position paper endorsed by the Italian Society of Nephrology.
    Bianchi S; Aucella F; De Nicola L; Genovesi S; Paoletti E; Regolisti G
    J Nephrol; 2019 Aug; 32(4):499-516. PubMed ID: 31119681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of hyperkalemia in Germany - a real world evidence study assessing the treatment and costs of hyperkalemia.
    Haas JS; Krinke KS; Maas C; Hardt T; Barck I; Braun S
    BMC Nephrol; 2020 Aug; 21(1):332. PubMed ID: 32770956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of a pre-ESRD pay-for-performance programme in advanced chronic kidney disease patients.
    Hsieh HM; Lin MY; Chiu YW; Wu PH; Cheng LJ; Jian FS; Hsu CC; Hwang SJ
    Nephrol Dial Transplant; 2017 Jul; 32(7):1184-1194. PubMed ID: 28486670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of home telemonitoring in chronic kidney disease patients at different stages by a pragmatic randomized controlled trial (eNephro): rationale and study design.
    Thilly N; Chanliau J; Frimat L; Combe C; Merville P; Chauveau P; Bataille P; Azar R; Laplaud D; Noël C; Kessler M
    BMC Nephrol; 2017 Apr; 18(1):126. PubMed ID: 28381266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study.
    Roger SD; Lavin PT; Lerma EV; McCullough PA; Butler J; Spinowitz BS; von Haehling S; Kosiborod M; Zhao J; Fishbane S; Packham DK
    Nephrol Dial Transplant; 2021 Jan; 36(1):137-150. PubMed ID: 32030422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare resource utilisation and cost associated with elevated potassium levels: a Danish population-based cohort study.
    Kim K; Thomsen RW; Nicolaisen SK; Hasvold LP; Palaka E; Sørensen HT
    BMJ Open; 2019 Apr; 9(4):e026465. PubMed ID: 30940761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
    Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
    BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease.
    Schlackow I; Kent S; Herrington W; Emberson J; Haynes R; Reith C; Wanner C; Fellström B; Gray A; Landray MJ; Baigent C; Mihaylova B;
    Heart; 2017 Dec; 103(23):1880-1890. PubMed ID: 28780579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CKD stage at nephrology referral and factors influencing the risks of ESRD and death.
    Sud M; Tangri N; Levin A; Pintilie M; Levey AS; Naimark DM
    Am J Kidney Dis; 2014 Jun; 63(6):928-36. PubMed ID: 24485146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of CKD patients receiving outpatient nephrology care in Italy.
    De Nicola L; Chiodini P; Zoccali C; Borrelli S; Cianciaruso B; Di Iorio B; Santoro D; Giancaspro V; Abaterusso C; Gallo C; Conte G; Minutolo R;
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2421-8. PubMed ID: 21817127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question.
    Pacilio M; Minutolo R; Garofalo C; Liberti ME; Conte G; De Nicola L
    J Nephrol; 2016 Apr; 29(2):153-161. PubMed ID: 26584810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
    Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
    BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperkalemia Recurrence Following Medical Nutrition Therapy in Patients with Stage 3-4 Chronic Kidney Disease: The REVOLUTIONIZE I Real-World Study.
    Rowan CG; Agiro A; Chan KA; Colman E; White K; Desai P; Dwyer JP
    Adv Ther; 2024 Jun; 41(6):2381-2398. PubMed ID: 38687454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CKD Outcomes and Practice Patterns Study (CKDopps): Rationale and Methods.
    Mariani L; Stengel B; Combe C; Massy ZA; Reichel H; Fliser D; Pecoits-Filho R; Lopes AA; Yamagata K; Wada T; Wong MM; Speyer E; Port FK; Pisoni RL; Robinson BM
    Am J Kidney Dis; 2016 Sep; 68(3):402-13. PubMed ID: 27113505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergency Department Use among Patients with CKD: A Population-Based Analysis.
    Ronksley PE; Tonelli M; Manns BJ; Weaver RG; Thomas CM; MacRae JM; Ravani P; Quinn RR; James MT; Lewanczuk R; Hemmelgarn BR
    Clin J Am Soc Nephrol; 2017 Feb; 12(2):304-314. PubMed ID: 28119410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.